Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC7696 | FMK Featured |
Fmk is an irreversible ribosomal S6 kinase inhibitor 1/2 inhibitor.
More description
|
![]() |
DC10751 | M2698 Featured |
M2698 is a potent dual-inhibitor of p70S6K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrier.
More description
|
![]() |
DC7943 | LYS6K2(LY2584702) tosylate salt Featured |
LY-2584702 is an orally available inhibitor of p70S6K signaling; inhibits p70S6K and prevents phosphorylation of the S6 subunit of ribosomes.
More description
|
![]() |
DC8812 | LJI-308 Featured |
LJI308 is a selective and potent RSK inhibitor.
More description
|
![]() |
DC8811 | LJH-685 Featured |
LJH685 is a selective and potent RSK inhibitor.
More description
|
![]() |
DC7098 | BI-D1870 Featured |
BI-D1870 is a small molecule, specific inhibitor of p90 RSK (ribosomal S6 kinase) isoforms RSK1, RSK2, RSK3 and RSK4, both in vitro and in vivo, with IC50s are 31 nM, 24 nM, 18 nM, 15 nM, respectively.
More description
|
![]() |
DC7599 | SC1(Pluripotin) Featured |
SC1(Pluripotin) is a sustainer of mES self-renewal and ERK 1 inhibitor
More description
|
![]() |
DC47347 | RSK4-IN-1 |
RSK4-IN-1 is identified with potent RSK4 inhibitory activity with an IC50 value of 9.5 nM.
More description
|
![]() |
DC41328 | Eudesmin |
Eudesmin ((-)-Eudesmin) impairs adipogenic differentiation via inhibition of S6K1 signaling pathway. Eudesmin possesses diverse therapeutic effects, including anti-tumor, anti-inflammatory, and anti-bacterial activities.
More description
|
![]() |
DC8239 | SL 0101-1 |
SL 0101-1 is a selective inhibitor of p90 Rsk (ribosomal S6 kinase) (IC50 = 89 nM for Rsk-2).
More description
|
![]() |
DC9617 | CMK |
CMK is a RSK2 kinase inhibitor.
More description
|
![]() |